Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1973-06-12
1976-05-11
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424164, 424359, 424366, 424361, 424362, 424363, A61K 2902
Patent
active
039564762
ABSTRACT:
An aqueous barium sulfate contrast medium which comprises barium sulfate, carbon dioxide, a suspending agent and an additive selected from the group consisting of ascorbic acid, erythorbic acid and a water-soluble salt thereof, the barium sulfate concentration being at least 750 grams per liter of the medium, the carbon dioxide concentration being 0.2 to 4 gas volumes and the additive concentration being in the range of 1 mg% to 150 mg% is disclosed.
REFERENCES:
patent: 2680089 (1954-06-01), Lowy
patent: 2746906 (1956-05-01), Novak et al.
patent: 3235462 (1966-02-01), Wolfson
patent: 3236735 (1966-02-01), Brown
patent: 3539682 (1970-11-01), Eriksson
patent: 3689630 (1972-09-01), Kikuchi et al.
Daigo Koji
Oda Kyuzo
Okuyama Shinichi
Clarke Vera C.
Friedman Stanley J.
Sakai Chemical Industry Company Ltd.
LandOfFree
Barium sulfate contrast medium containing ascorbic acid, erythor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Barium sulfate contrast medium containing ascorbic acid, erythor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Barium sulfate contrast medium containing ascorbic acid, erythor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1304259